Wikidata

(Q63320180)

English

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
An Open-label, Single-arm, Multicenter, Phase II Study to Assess the Efficacy and Safety of Aiyi® (Tegafur Gimeracil Oteracil Potassium Capsule) as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer (English)
0 references
start time
December 2011
0 references
end time
April 2014
0 references
number of participants
30
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63320180&oldid=2149422465"